ビオフェルミン製薬(株)の貸借残高情報
| 主市場 | 業種 | 証券コード/EDINET | 英名称 |
|---|---|---|---|
| 東証1部 | 医薬品 | 4517/E00960 | BIOFERMIN PHARMACEUTICAL CO.,LTD. |
| 公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
|---|---|---|---|---|---|---|---|---|---|
| 2013/12/20 | 日証協 | 22,356株 | +2.79% | 4,414株 | +2.65% | 24,556株 | -6.66% | 4,400株 | -3.28% |
| 2013/12/13 | 日証協 | 21,749株 | -6.45% | 4,300株 | -70.14% | 26,307株 | +0.38% | 4,549株 | +249.92% |
| 2013/12/06 | 日証協 | 23,249株 | -2.52% | 14,400株 | -1.37% | 26,207株 | -2.24% | 1,300株 | +160% |
| 2013/11/29 | 日証協 | 23,849株 | +3.02% | 14,600株 | -1.35% | 26,807株 | +4.27% | 500株 | -28.57% |
| 2013/11/22 | 日証協 | 23,149株 | +11.57% | 14,800株 | +5.73% | 25,708株 | +1.18% | 700株 | -61.11% |
| 2013/11/15 | 日証協 | 20,749株 | +1.21% | 13,998株 | -62.07% | 25,408株 | -3.42% | 1,800株 | -87.67% |
| 2013/11/08 | 日証協 | 20,500株 | +57.69% | 36,900株 | +319.32% | 26,308株 | -2.59% | 14,600株 | -28.08% |
| 2013/11/01 | 日証協 | 13,000株 | +36.84% | 8,800株 | +60% | 27,008株 | +94.19% | 20,300株 | +625% |
| 2013/10/25 | 日証協 | 9,500株 | +6.74% | 5,500株 | +96.43% | 13,908株 | +12.09% | 2,800株 | +75% |
| 2013/10/18 | 日証協 | 8,900株 | +36.92% | 2,800株 | 0% | 12,408株 | +1.65% | 1,600株 | -56.77% |
| 2013/10/11 | 日証協 | 6,500株 | +20.37% | 2,800株 | +33.33% | 12,207株 | +6.08% | 3,701株 | +85.05% |
| 2013/10/04 | 日証協 | 5,400株 | +14.89% | 2,100株 | +16.67% | 11,507株 | +12.75% | 2,000株 | -55.59% |
| 2013/09/27 | 日証協 | 4,700株 | -47.78% | 1,800株 | -76% | 10,206株 | -0.98% | 4,503株 | +400.33% |
| 2013/09/20 | 日証協 | 9,000株 | +13.92% | 7,500株 | +108.33% | 10,307株 | -15.56% | 900株 | +50% |
| 2013/09/13 | 日証協 | 7,900株 | -59.49% | 3,600株 | -77.57% | 12,207株 | -26.05% | 600株 | -85.37% |
| 2013/09/06 | 日証協 | 19,500株 | +13.99% | 16,049株 | +34.37% | 16,508株 | +0.61% | 4,100株 | -71.53% |
| 2013/08/30 | 日証協 | 17,107株 | +24.8% | 11,944株 | +285.29% | 16,408株 | +31.18% | 14,400株 | +269.23% |
| 2013/08/23 | 日証協 | 13,707株 | 0% | 3,100株 | 0% | 12,508株 | +1.62% | 3,900株 | +875% |
| 2013/08/16 | 日証協 | 13,707株 | 0% | 0株 | -100% | 12,308株 | -1.6% | 400株 | -93.65% |
※株式分割は考慮していませんのでご注意ください。